Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 215471, 7 pages
http://dx.doi.org/10.1155/2014/215471
Review Article

The Roles of Regulatory B Cells in Cancer

Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China

Received 23 February 2014; Revised 28 April 2014; Accepted 12 May 2014; Published 2 June 2014

Academic Editor: Yi Zhang

Copyright © 2014 Yan He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Disis, “Immune regulation of cancer,” Journal of Clinical Oncology, vol. 28, no. 29, pp. 4531–4538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Swann and M. J. Smyth, “Immune surveillance of tumors,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1137–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Kim, M. Emi, and K. Tanabe, “Cancer immunoediting from immune surveillance to immune escape,” Immunology, vol. 121, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, “Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation,” Immunity, vol. 16, no. 2, pp. 219–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Yanaba, J.-D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder, “A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses,” Immunity, vol. 28, no. 5, pp. 639–650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Amu, S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger, and P. G. Fallon, “Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model,” Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1114.e8–1124.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Matsushita, K. Yanaba, J.-D. Bouaziz, M. Fujimoto, and T. F. Tedder, “Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression,” Journal of Clinical Investigation, vol. 118, no. 10, pp. 3420–3430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Watanabe, N. Ishiura, H. Nakashima et al., “Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity,” Journal of Immunology, vol. 184, no. 9, pp. 4801–4809, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton, “B cells regulate autoimmunity by provision of IL-10,” Nature Immunology, vol. 3, no. 10, pp. 944–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Evans, K. A. Chavez-Rueda, A. Eddaoudi et al., “Novel suppressive function of transitional 2 B cells in experimental arthritis,” Journal of Immunology, vol. 178, no. 12, pp. 7868–7878, 2007. View at Google Scholar · View at Scopus
  11. P. A. Blair, K. A. Chavez-Rueda, J. G. Evans et al., “Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice,” Journal of Immunology, vol. 182, no. 6, pp. 3492–3502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Di Caro, B. Phillips, C. Engman et al., “Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice,” PLoS ONE, vol. 9, no. 1, Article ID e83575, 2014. View at Google Scholar
  13. C. Mauri and A. Bosma, “Immune regulatory function of B cells,” Annual Review of Immunology, vol. 30, pp. 221–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Ding, M. Yeung, G. Camirand et al., “Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice,” Journal of Clinical Investigation, vol. 121, no. 9, pp. 3645–3656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Rafei, J. Hsieh, S. Zehntner et al., “A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties,” Nature Medicine, vol. 15, no. 9, pp. 1038–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Nishimura, I. Manabe, S. Takaki et al., “Adipose natural regulatory B cells negatively control adipose tissue inflammation,” Cell Metabolism, vol. 18, no. 5, pp. 759–766, 2013. View at Google Scholar
  17. Y. Iwata, T. Matsushita, M. Horikawa et al., “Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells,” Blood, vol. 117, no. 2, pp. 530–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Blair, L. Y. Noreña, F. Flores-Borja et al., “CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients,” Immunity, vol. 32, no. 1, pp. 129–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kessel, T. Haj, R. Peri et al., “Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells,” Autoimmunity Reviews, vol. 11, no. 9, pp. 670–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Kalampokis, A. Yoshizaki, and T. F. Tedder, “IL-10-producing regulatory B cells (B10 cells) in autoimmune disease,” Arthritis Research and Therapy, vol. 15, no. 1, article S1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. N. Byrne and G. M. Halliday, “B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity,” Journal of Investigative Dermatology, vol. 124, no. 3, pp. 570–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Miles, J. Heaney, Z. Sibinska et al., “A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 3, pp. 887–892, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Yoshizaki, T. Miyagaki, D. J. Dilillo et al., “Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions,” Nature, vol. 491, no. 7423, pp. 264–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Lindner, K. Dahlke, K. Sontheimer et al., “Interleukin 21-induced granzyme b-expressing b cells infiltrate tumors and regulate t cells,” Cancer Research, vol. 73, no. 8, pp. 2468–2479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Jin, Y. Hamaguchi, T. Matsushita et al., “B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells,” Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1674.e9–1682.e9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Yang, J. Yang, Y. Chu et al., “T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-Prone MRL/lpr mice,” PLoS ONE, vol. 8, no. 4, Article ID e62855, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Matsumoto, Y. Fujii, A. Baba, M. Hikida, T. Kurosaki, and Y. Baba, “The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production,” Immunity, vol. 34, no. 5, pp. 703–714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Matsushita, M. Horikawa, Y. Iwata, and T. F. Tedder, “Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis,” Journal of Immunology, vol. 185, no. 4, pp. 2240–2252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-C. Wong, A.-L. Puaux, M. Chittezhath et al., “Macrophage polarization to a unique phenotype driven by B cells,” European Journal of Immunology, vol. 40, no. 8, pp. 2296–2307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D. L. Kaufman, “Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice,” Journal of Immunology, vol. 167, no. 2, pp. 1081–1089, 2001. View at Google Scholar · View at Scopus
  31. Y. Liu, Y. Chen, Z. Li et al., “Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice,” European Journal of Immunology, vol. 43, no. 11, pp. 2907–2918, 2013. View at Google Scholar
  32. N. A. Carter, E. C. Rosser, and C. Mauri, “Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis,” Arthritis Research and Therapy, vol. 14, no. 1, article R32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. A. Carter, R. Vasconcellos, E. C. Rosser et al., “Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells,” Journal of Immunology, vol. 186, no. 10, pp. 5569–5579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Flores-Borja, A. Bosma, D. Ng et al., “CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation,” Science Translational Medicine, vol. 5, no. 173, Article ID 173ra23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ray, S. Basu, C. B. Williams, N. H. Salzman, and B. N. Dittel, “A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand,” Journal of Immunology, vol. 188, no. 7, pp. 3188–3198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Sorrentino, S. Morello, G. Forte et al., “B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 10, pp. 1369–1379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. J. DiLillo, K. Yanaba, and T. F. Tedder, “B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice,” Journal of Immunology, vol. 184, no. 7, pp. 4006–4016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Q. Li, S. Teitz-Tennenbaum, E. J. Donald, M. Li, and A. E. Chang, “In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy,” Journal of Immunology, vol. 183, no. 5, pp. 3195–3203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Shah, A. A. Divekar, S. P. Hilchey et al., “Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells,” International Journal of Cancer, vol. 117, no. 4, pp. 574–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Qin, G. Richter, T. Schüler, S. Ibe, X. Cao, and T. Blankenstein, “B cells inhibit induction of T cell-dependent tumor immunity,” Nature Medicine, vol. 4, no. 5, pp. 627–630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Inoue, W. W. Leitner, B. Golding, and D. Scott, “Inhibitory effects of B cells on antitumor immunity,” Cancer Research, vol. 66, no. 15, pp. 7741–7747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Zhang, Y. Eliav, S.-U. Shin et al., “B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion,” Cancer Immunology, Immunotherapy, vol. 62, no. 1, pp. 87–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. B. Olkhanud, D. Baatar, M. Bodogai et al., “Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells,” Cancer Research, vol. 69, no. 14, pp. 5996–6004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. K. E. De Visser, L. V. Korets, and L. M. Coussens, “De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent,” Cancer Cell, vol. 7, no. 5, pp. 411–423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. N. Houghton, H. Uchi, and J. D. Wolchok, “The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword,” Cancer Cell, vol. 7, no. 5, pp. 403–405, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Schreiber, T. H. Wu, J. Nachman, and D. A. Rowley, “Immunological enhancement of primary tumor development and its prevention,” Seminars in Cancer Biology, vol. 10, no. 5, pp. 351–357, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Ammirante, J.-L. Luo, S. Grivennikov, S. Nedospasov, and M. Karin, “B-cell-derived lymphotoxin promotes castration-resistant prostate cancer,” Nature, vol. 464, no. 7286, pp. 302–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Andreu, M. Johansson, N. I. Affara et al., “FcRγ Activation regulates inflammation-associated squamous carcinogenesis,” Cancer Cell, vol. 17, no. 2, pp. 121–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Barbera-Guillem, M. B. Nelson, B. Barr et al., “B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion,” Cancer Immunology Immunotherapy, vol. 48, no. 10, pp. 541–549, 2000. View at Google Scholar · View at Scopus
  50. J.-M. Berthelot, C. Jamin, K. Amrouche, B. Le Goff, Y. Maugars, and P. Youinou, “Regulatory B cells play a key role in immune system balance,” Joint Bone Spine, vol. 80, no. 1, pp. 18–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra, “IL-10 inhibits cytokine production by activated macrophages,” Journal of Immunology, vol. 147, no. 11, pp. 3815–3822, 1991. View at Google Scholar · View at Scopus
  52. M. J. Townsend, J. G. Monroe, and A. C. Chan, “B-cell targeted therapies in human autoimmune diseases: an updated perspective,” Immunological Reviews, vol. 237, no. 1, pp. 264–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. P. B. Olkhanud, B. Damdinsuren, M. Bodogai et al., “Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells,” Cancer Research, vol. 71, no. 10, pp. 3505–3515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. P. B. Olkhanud, Y. Rochman, M. Bodogai et al., “Thymic stromal lymphopoietin is a key mediator of breast cancer progression,” Journal of Immunology, vol. 186, no. 10, pp. 5656–5662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Lelekakis, J. M. Moseley, T. J. Martin et al., “A novel orthotopic model of breast cancer metastasis to bone,” Clinical and Experimental Metastasis, vol. 17, no. 2, pp. 163–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Z. Song, J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz, “IL-2 is essential for TGF-β to convert naive CD4+CD25—cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells,” Journal of Immunology, vol. 178, no. 4, pp. 2018–2027, 2007. View at Google Scholar · View at Scopus
  57. K. Wejksza, L.-C. Catalina, M. Bodogai et al., “Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B Cells via peroxisome proliferator-activated receptor α,” Journal of Immunology, vol. 190, no. 6, pp. 2575–2584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Horikawa, V. Minard-Colin, T. Matsushita, and T. F. Tedder, “Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice,” Journal of Clinical Investigation, vol. 121, no. 11, pp. 4268–4280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Bodogai, C. L. Chang, K. Wejksza et al., “Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L,” Cancer Research, vol. 73, no. 7, pp. 2127–2138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Minard-Colin, Y. Xiu, J. C. Poe et al., “Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV,” Blood, vol. 112, no. 4, pp. 1205–1213, 2008. View at Google Scholar
  61. T. Schioppa, R. Moore, R. G. Thompson et al., “B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 26, pp. 10662–10667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. T. W. Lebien and T. F. Tedder, “B lymphocytes: how they develop and function,” Blood, vol. 112, no. 5, pp. 1570–1580, 2008. View at Publisher · View at Google Scholar · View at Scopus